JACC Asia

Efficacy and Safety of Quarterly Dosing SHR-1918 in Patients With Suboptimally Controlled Hyperlipidemia

By Wei Zhong, Jing Zhang, Dan Zhu, ZhiXiong Zhong

Graphical abstract from JACC Asia — Graphical abstract. Zhong et al.

Randomised trial in 44 peopleInterventions

24 weeks, double-blind, placebo-controlled, registered NCT06471218, declared ties to: Hengrui

The paper

Wei Zhong, Jing Zhang, Dan Zhu, ZhiXiong Zhong

Meizhou City People's Hospital

JACC Asia, 3 Sep 2026

doi.org/10.1016/j.jacasi.2026.07.017 PubMed 42714362

JCI Insight4 Oct 2026
Mild caloric restriction accelerates atherosclerosis in mice
Circulation Population Health and Outcomes4 Oct 2026
Martin-Hopkins LDL equation best predicts cardiovascular risk
The Lancet Regional Health Western Pacific4 Oct 2026
Cardiovascular risk from metabolic burden weakens with age
Frontiers in Endocrinology4 Oct 2026
Six blood metabolites distinguish metabolic health in obesity